Catalyst Wire Dossier Catalyst Wire Dossier

Vorapaxar (Zontivity)

vorapaxar · Merck & Co., Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vorapaxar (Zontivity), covering 2014-08-15 to 2014-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016) [Phase 2]

See pricing